北京时间2025年02月08日02时17分，Bolt Biotherapeutics（BOLT.us）股票出现异动，股价急速下跌5.20%。截至发稿，该股报0.474美元/股，成交量6.1873万股， 换手率 0.16%，振幅4.00%。

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bolt announced a private placement of 1.06 million shares.

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Bolt Metals Corp. has revised the terms of its Quebec Flow-Through private placement to offer up to 8,000,000 ...

Boston Scientific Corporation BSX recently entered into a definitive agreement to acquire Bolt Medical, Inc. — an intravascular lithotripsy (IVL) advanced laser-based platform developer.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bolt Medical’s Bolt IVL system is designed ... You can see the complete list of today’s Zacks #1 Rank stocks here. VCYT’s earnings surpassed estimates in each of the trailing four quarters ...